Vigil Neuroscience Shares Trade in Narrow Range Ahead of Sanofi Acquisition
10.09.2025 - 08:54:04
The investment narrative for Vigil Neuroscience is now singularly focused on its impending acquisition by pharmaceutical titan Sanofi. The biotech firm?s shares are trading near the agreed-upon buyout price of $8.00 per share, signaling strong market confidence that the transaction will be finalized.
Trading activity has become tightly range-bound, with the stock currently hovering around $8.05?just marginally above the acquisition offer. This price action reflects a market that views the deal as a near certainty. The 52-week trading window highlights this shift dramatically, with the stock having reached a high of $8.10 after plumbing a low of $1.31. The minimal spread between the current price and the offer indicates that any potential for independent share price appreciation has been effectively... Read more...
